Phoenix Fire launches angel fund focused on women entrepreneurs
“We need to make sure that everybody has a seat at the table.”
A year after launch, Backbone Angels is closing gaps felt by underrepresented founders
Backbone’s portfolio is 72 percent first-time founders and 56 percent women of colour.
Mayday marks calendar year with $3.8 million CAD to help remote workers improve their time management
Amid a saturated market, Jeremy Bell doesn’t want to just “build another calendar.”
Ontario government announces launch of new IP agency
The official launch follows years of work around a provincial IP strategy.
Invest Ontario appoints CEO as InBC bolsters team with Telus exec
Ontario and British Columbia are building their respective agencies to foster local innovation.
Canadian venture capital investment hits all-time high of $14.2 billion in 2021
CVCA CEO: “it signals an extremely healthy ecosystem.”
ApplyBoard CEO eyes public markets as TSX rings opening bell in Waterloo Region for first time
“I hear the ring in my [ear], so I want to ring the bell.”
Hopper continues acquisition spree with Parisian airline travel tech Smooss
Hopper looks to bolster its B2B offering as it expands into new verticals.
eSentire to be valued at $1.1 billion USD following $325 million deal
Only $100 million in primary capital will go to the company.
New report on Canadian venture, private equity landscape shows firms failing when it comes to inclusion side of D&I
Women partners are six times more likely to report harassment or feel opinions not valued.
Paper secures $343 million CAD with US schools drawn to its remote tutoring tech
Paper doubled the number of students on its platform to two million since last year.
Micruity aims to “pensionize” 401(k) plans as it lands $6.5 million CAD seed round
Franklin Templeton and Allianz Life both made strategic investments in Micruity.
Raquel Urtasun’s Waabi unveils “revolutionary” autonomous vehicle testing simulator
Waabi claims it’s the “ultimate school for self-driving vehicles.”
Canadian biotech leader Clarissa Desjardins secures $63 million CAD for Congruence Therapeutics
PerkinElmer and Ipsen purchased two of Desjardins’ previous companies.